Rice bakanae disease (RBD) caused by Fusarium
fujikuroi is a widespread and destructive disease of rice.
It is urgent to
introduce a new class of fungicide to manage the fungicidal resistance
problem and effectively control the disease. Azoxystrobin (AZO) is
an active fungicide with a broad antifungal spectrum, while its activity
against F. fujikuroi is not well
investigated. In this study, the baseline sensitivity of F. fujikuroi to AZO was established by testing the
sensitivity of 100 isolates, collected from Anhui Province of China.
The mechanism of resistance to AZO was also investigated. AZO exhibited
a strong activity against the 100 F. fujikuroi isolates with EC50 values of 0.822 ± 0.285 and 0.762
± 0.283 μg/mL for mycelial growth and conidial germination,
respectively, and both of the baseline sensitivity curves were validated
as unimodal curves. To investigate the resistance mechanism, six mutants
with resistance factor (RF) values >50 were generated from wild-type
sensitive strains through UV mutagenesis, and sequence analysis showed
that mutation G143A in cyt b conferred the resistance
to AZO. Mycelial growth, conidia production, pathogenicity, and ATP
production were decreased in all six resistant mutants as compared
to the parental strains, indicating the fitness penalties in this
phenotype of resistance mutation. In addition, the cross-resistance
assay showed that there was no cross-resistance between AZO and carbendazim,
prochloraz, phenamacril, or pydiflumetofen. AZO can be an efficient
candidate to control RBD in China with moderate to low fungal resistance
risk, but continuous resistance monitoring should be performed during
the application of this fungicide.
Pomegranate crown rot caused by Coniellagranati is one of the most severe diseases of pomegranate. To date, no fungicides have been registered for controlling this disease in China. Pyraclostrobin, belonging to strobilurin fungicides, has a broad spectrum of activity against many phytopathogens. In this study, based on the mycelial growth and conidial germination inhibition methods, we investigated the biological activity of pyraclostrobin against C. granati at the presence of 50 μg/mL SHAM using 80 isolates collected from different orchards in China during 2012-2018. The EC50 (50% effective concentration) values ranged from 0.040-0.613 μg/mL for mycelial growth and 0.013-0.110 μg/mL for conidium germination, respectively. Treated with pyraclostrobin, the hyphae morphology changed and conidial production of C. granati decreased significantly. The result of transmission electron microscope showed that treatment of pyraclostrobin could make the cell wall thinner, and lead to ruptured cell membrane and formation of intracellular organelle autophagosomes. The pyraclostrobin showed good protective and curative activities against C. granati on detached pomegranate fruits. In field trials, pyraclostrobin showed excellent control efficacy against this disease in which the treatment of 25% pyraclostrobin EC 1000× provided 92.25% and 92.58% control efficacy in 2019 and 2020, respectively, significantly higher than that of other treatments. Therefore, pyraclostrobin could be a candidate fungicide for the control of pomegranate crown rot.
Sustainable chemical control for rice bacterial leaf blight caused by
Xanthomonas oryzae
pv.
oryzae
need to be developed due to limited bactericides with high efficiency, low cost, and low toxicity in China. This present study verified a broad-spectrum fungicide named Xinjunan possessing a specific high toxicity to
Xanthomonas
pathogens, which were further confirmed by affecting the cellular iron metabolism of
Xoo
as a novel mode of action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.